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Abstract.  Protein sequence requirements for cleavage 
of the signal peptide from the Rous sarcoma virus gly- 
coprotein have been investigated through the use of 
deletion mutagenesis. The phenotypes of these mutants 
have been characterized by expression of the cloned, 
mutated env genes in CV-1 cells using a late replace- 
ment SV40 vector. The deletion mutations were gener- 
ated by Bal31  digestion at the XhoI site located near 
the 5' end of the ceding sequence for the structural 
protein gp85,  which is found at the amino terminus of 
the precursor glycoprotein, Pr95.  The results of ex- 
periments with three mutants (X1, X2, and X3) are 
presented.  Mutant X1 has a  14 amino acid deletion en- 
compassing amino acids 4-17 of gp85, which results in 
the loss of one potential glycosylation site.  In mutants 
X2 and X3 the amino terminal nine and six amino 
acids, respectively, of gp85 are deleted.  During the 
biosynthesis of all three mutant polypeptides, the 
signal peptide is efficiently and accurately cleaved 
from the nascent protein,  even though in mutants X2 
and X3 the cleavage site itself has been altered.  In 
these mutants the alanine/aspartic  acid cleavage site 
has been mutated to alanine/asparagine  and alanine/ 
glutamine,  respectively. These-results are consistent 
with the concept that sequences C-terminal to the sig- 
nal peptidase site are unimportant in defining the site 
of cleavage in eucaryotes. 
Mutants X2 and X3 behave like wild-type with 
respect to protein glycosylation, palmitic acid addition, 
cleavage to gp85 and gp37, and expression on the cell 
surface.  Mutant X1, on the other hand,  is defective in 
intracellular transport.  Although it is translocated 
across the rough endoplasmic reticulum and core- 
glycosylated, its transport appears to be blocked at an 
early Golgi compartment.  No terminal glycosylation of 
the protein,  cleavage of the precursor protein to the 
mature products, or expression on the cell surface is 
observed. The deletion in X1 thus appears to destroy 
signals required for export to the cell surface. 
M 
ANY cellular  and  viral  gene products  are trans- 
ported, from their site of synthesis  on the rough 
endoplasmic  reticulum,  through  the  secretory 
pathway to the cell surface, where they are released as solu- 
ble products or inserted into the plasma membrane of the 
cell. Whereas the general principles of this transport path- 
way are understood, many of the finer details  remain to be 
elucidated and attempts are being made to use both biochem- 
ical and genetic approaches to this end (reviewed by Sabatini 
et al.,  1982; Silhavy et al.,  1983; Gething,  1985). We have 
chosen the envelope glycoprotein gene of Rous sarcoma vi- 
rus (RSV) ~  for genetic analyses,  with the goal of identifying 
and characterizing  protein domains that might play impor- 
tant roles in glycoprotein transport (Wills et al., 1983; 1984). 
We describe in this paper mutants in the amino-terminus  of 
the env gene product that address both the topic of protein 
1. Abbreviations used in this paper:  HA,  hemagglutinin; RSV, Rous sar- 
coma virus. 
sorting  and  that  of the  cotranslational  proteolytic events 
necessary to remove amino-terminal  signal  sequences. 
Secretory and membrane-spanning  proteins appear to con- 
tain specific amino acid structures that serve as "sorting sig- 
nais; in addition  to those sequences that confer specialized 
functions.  These signals are recognized by cellular compo- 
nents that guide these proteins through  the appropriate as- 
sembly and  sorting  processes and distribute them to their 
respective destinations.  Insights  into these mechanisms has 
largely come from the study of cell surface and viral enve- 
lope glycoproteins  (reviewed  by Michaelis and Beckwith, 
1982; Sabatini  et al.,  1982; Silhavy  et al.,  1983; Gething, 
1985).  Typical  membrane  glycoproteins  appear  to  have 
several functional domains that may be involved in transport. 
The most frequently encountered organization  includes:  (a) 
an amino-terminal  signal peptide that is responsible for ini- 
tiating  translocation  of the protein across the endoplasmic 
reticulum  and that is usually cleaved off by a specific pepti- 
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main, which may confer a specific function on the protein; 
(c) a hydrophobic anchor that spans the lipid bllayer; and (d) 
a cytoplasmic tail. There are probably additional signals yet 
to be delineated, which are responsible for directing such 
glycoproteins through  different subcellular  compartments 
such as the cis- and trans-Golgi cisternae and transport vesi- 
cles. For example, while influenza glycoproteins are sent to 
the apical membrane, the vesicular stomatitis virus glyco- 
protein is transported to the basolateral membranes of po- 
larized  cells  (Roth  et  al.,  1983; Rodriguez-Boulan  and 
Sabatini, 1978). Also, in certain cell types some cellular pro- 
teins are stored in secretory granules and are secreted only 
when induced, while other proteins are targeted to the consti- 
tutive pathway and are released from the cell immediately 
(Kelly, 1985). These less well defined sorting signals are as- 
sumed to be inherent structural features of each protein, but 
have yet to be identified. 
After translocation of a nascent chain across the endoplas- 
mic reticulum has been initiated, the signal peptide is re- 
moved. This cleavage is carded out by signal peptidase, a 
cellular gene product. Two classes of signal peptidases have 
been  described.  A  signal  peptidase  of Escherichia  coli 
(SPase I) has been cloned'into pBR322 (Date and Wickner, 
1981), and has been shown to accurately cleave eucaryotic 
precursor proteins as well as bacterial protein precursors 
(Talmadge et al.,  1980). Conversely, the eucaryotic signal 
peptidase will accurately cleave procaryotic proteins (Watts 
et al.,  1983). The  latter enzyme has  been  studied using 
detergent-solubilized dog pancreas signal peptidase (Jackson 
and White,  1981) and hen oviduct signal peptidase (Lively 
and Walsh, 1983), demonstrating that it is an integral mem- 
brane protein that can be solubilized only when the lipid 
bilayer is dissolved. A second procaryotic signal peptidase 
(E. coli SPase II) has been described that is specific for pro- 
lipoproteins (Hussain et al.,  1982; Tokunaga et al.,  1982) 
and membrane-bound penicillinases (Nielsen and Lampen, 
1982). This enzyme maps to a different locus on the E.  coli 
genome  and  requires  a  glyceride-modified cysteine  for 
cleavage. 
Perlman and Halvorson (1983) and von Heijne (1984) have 
examined the sequences of a number of membrane proteins 
and have described amino acid sequence patterns that allow 
prediction of signal peptidase cleavage sites with >90% ac- 
curacy. The most striking feature of signal peptidase cleavage 
sites is the presence of  an amino acid with a small, uncharged 
side chain at the carboxy-terminus of the signal peptide. The 
most common amino acids found at this position are alanine 
and glycine. From their statistical analyses, the peptidase 
cleavage site appears to be determined by sequences within 
the signal peptide and not by sequences beyond the cleavage 
site.  This is in contrast to the observations that mutations 
within the structural protein itself appear to prevent signal 
peptidase cleavage of the/araB gene product and the M13 
coat protein (Emr and Bassford, 1982; Benson and Silhavy, 
1983; Russel and Model,  1981). 
We report here on studies on the signal peptidase process- 
ing and intracellular transport of  the RSV envelope glycopro- 
tein through the construction, in vitro, of mutated envelope 
genes, and by expression of such genes from an SV40 vector 
in primate cells. The RSV envelope glycoprotein is represen- 
tative of  highly glycosylated  membrane proteins that undergo 
proteolytic processing during transport to the plasma mem- 
brane. The env gene encodes a precursor protein (Pr95) that 
is cleaved late in the Golgi (Hunter et al., manuscript in prep- 
aration) to the two viral structural proteins, gp85 and gp37. 
The larger component, gp85, is the receptor-binding domain 
of the glycoprotein complex,  whereas gp37,  a  membrane 
spanning protein, serves to anchor the complex into the lipid 
bilayer. These two glycoproteins mediate viral attachment to, 
and penetration of susceptible cells thus initiating the pro- 
cess of infection. A hydrophobic signal sequence that medi- 
ates translocation across the rough endoplasmic reticulum is 
located within a long amino-terminal signal peptide; the lat- 
ter being cleaved cotranslationally by signal peptidase from 
Pr95. 
We previously reported preliminary results on a mutant of 
the RSV env gene that is cleaved normally despite a mutation 
at the signal peptidase site (Wills et al., 1983). We describe 
here three mutants of the RSV glycoprotein that have wild- 
type signal peptides but that have deletions in the amino- 
terminal portion of the mature protein adjacent to the signal 
peptidase cleavage site.  That these deletions have no effect 
on protein processing provides experimental support for the 
conclusions drawn from the study of compiled amino acid 
sequence data (Periman and Halvorson, 1983; von Heijne, 
1984). Indeed, signal peptide cleavage appears to be less sen- 
sitive to the deletion of sequences near the cleavage site than 
are signals required for transport and sorting, because one 
of these mutants (XI), which has a  14 amino acid deletion 
near the amino terminus of the mature protein, is not trans- 
ported past an early compartment of the Golgi apparatus. 
Materials and Methods 
Cells,  Viruses, and DNAs 
The coding  sequences for the env gene  of the Prague C strain  of RSV were 
moleculary  cloned into the ClaI and BamHI  sites of pATI53 after  excision 
from pATV-8 that contains the entire RSV genome (Katz et al., 1982; 
Schwartz et al., 1983). This recombinant  plasmid  containing  the env gene 
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Figure 1. Construction of amino-terminal mutants. (A) The Kprd- 
XbaI fragment of the RSV genome contains the entire env gene. A 
Clal linker was added at the KpnI end and a BamHI linker was 
added to the XbaI end of the RSV KpnI-XbaI fragment (solid bar). 
This fragment was ligated into the plasmid pAT153. Mutations were 
generated by Balm digestion from the unique XhoI site. (B) The 
HpaII site of SV40 was converted to a ClaI site by linker addition 
and the mutated ClaI-BamHI env fragment was ligated into this late 
replacement SV40 vector. The details of the construction are de- 
scribed in Materials and Methods. The direction of transcription is 
indicated by the arrows and the promoters are indicated by dashed 
lines. 
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Ia). 
All recombinant plasmids were propagated by transforming E. coli strain 
DH-1 (recA hsdR) (Maniatis et al.,  1982). Transformed DH-1 cells were 
grown in L broth containing ampicillin. A derivative of SV40 with the late 
region replaced by the RSV env gene was used as an expression vector 
(Gething  and Sambrook,  1981; Wills  et al.,  1983). For propagation  of 
recombinant virus, the late SV40 gene functions were supplied by mutant 
helper virus, d1-1055, that has a small deletion in the early region (Pipas 
et al., 1980, 1983). The SV40 vector containing the env gene in place of  late 
SV40 sequences was expressed in CV-I cells, a continuous line of African 
green monkey kidney cells (Acheson, 1981). CV-1 cells were grown in DUl- 
becco's modified Eagle's medium containing 10% fetal calf serum. 
In a natural infection with RSV, the 5' leader sequences for the env gene 
mRNA are derived from sequences at the 5' end of the RSV genome by a 
splicing event. The result is a signal peptide with six amino-terminal amino 
adds identical to the amino-terminus of the gag gene product (Schwartz et 
al., 1983; Hunter et al.,  1983; Ficht et al.,  1984). In the constructs used 
here, where no gag sequences exist, translation is initiated at a naturally oc- 
curring,  in frame, initiator codon (ATG) at the 5' end of the open reading 
frame that encompasses the env gene (Hunter et al., 1983). This results in 
the replacement of the six gag-related amino acids with eight amino acids 
encoded  upstream of the splice acceptor site. The protein product neverthe- 
less appears to be translated efficiently and transported normally through 
intracellular pathways  to the cell surface (Hunter et al., manuscript in prepa- 
ration; Wills et al.,  1984). 
Enzymes 
All DNA modification enzymes  including restriction  endonucleases,  T4 
DNA ligase, Klenow fragment of E.  coli DNA polymerase I, and Bal 31 
were purchased from Bethesda Research Laboratories (Gaithersburg, MD). 
All manipulations, reactions, and analysis of  DNAs were performed  accord- 
ing to the standard procedures described  in the Cold Spring Harbor cloning 
manual (Maniatis et al.,  1982). 
In Vitro Mutagenesis of the env Gene and 
Construction of  Recombinant  Viruses 
The KpnI-XbaI fragment of  pATV-8 that contains the env gene was inserted 
into a plasmid vector by blunt-ending with the Klenow fragment of DNA 
PolI and adding a ClaI linker to the KpnI end and a BamHI linker to the 
XbaI end (Fig. 1 A). This plasmid,  designated penvCla(+), was digested 
with XhoI at the unique site 13 base pairs (bp) 3' of the first codon of gp85, 
between the signal peptide leader sequence and the major portion of  the ma- 
ture  glycoprotein  coding  sequence  (Fig.  2).  The  restricted  ends  were 
trimmed by digestion with a double-strand exonuclease, Bal 31, to generate 
small deletions. Without further treatment the new ends were religated. The 
mntagenized env gene was excised from penvCla(+) by digestion with ClaI 
and BamHI and ligated into the ClaI and Baml-II sites of the SV40 expres- 
Figure 2.  Amino acid sequence deduced from DNA sequence of 
mutants Xl, X2, and X3.  The RSV glycoprotein is schematically 
represented: the location of  the hydrophobic signal sequence within 
the long (64 amino acid) leader peptide is denoted by a stippled bar, 
and the mature gp85 glycoprotein  by a slashed bar. The signal pepti- 
dase cleavage site in both the cartoon and the numbered amino acid 
sequence is denoted by a long arrow. The potential glycosylation 
site in the amino-terminus of gp85 is shown as a CHO. The amino 
acid sequence of the last seven amino acids of the leader peptide 
and the amino-terminal 18 amino acids of gp85 are shown for the 
wild-type gene product. The solid black bars show the length and 
position of the deletions in mutants X1,  X2, and X3. 
sion vector. The ClaI site in SV40 was generated by addition of Clal linker 
at the HpaII site. This construction placed the mutagenized env gene under 
control of the SV40 late promoter (Fig.  1 B). The DNA sequence for all 
mutants was determined by the Maxam-Gilbert procedure (Maxam and Gil- 
bert, 1980). 
The initial mutant constructions in which the env gene was placed at the 
altered SV40 HpalI site, did not give suitable levels of env gene expression 
(Wills et al., 1983). This appears to be due to initiation of translation at the 
SV40 agno gene ATG, located upstream from the env sequences, which pre- 
vents initiation from the env A'I'G  (Perez et al., manuscript in preparation). 
To increase expression, the mutant genes were cloned into an SV40 vector 
in which the agno ATG was deleted (Perez et al., manuscript in prepara- 
tion).  This vector is referred to as ASV.CB. 
For expression'of  the wild type env gene products, a similar construction 
was made except that viral sequences, with only the Xbal site converted to 
a BamHI site, were ligated directly between the SV40 KpnI and BamH] sites 
(Hunter et al., manuscript in preparation). This construction is referred to 
as SV.KB. Thus, SV.KB differs from the mutant constructs in that it lacks 
the 50 bp KpnI-HpalI fragment that contains the SV40 agno gene ATG. The 
levels of  mutant and wild-type env gene expression from ASV.CB  were simi- 
lar to SV.KB, and their protein products were indistinguishable. 
Nomenclature 
The  mutant  constructions  described  here  have  been  designated 
ASV.env.CBtXn, where ASV signifies the SV40 vector with the agno gene 
ATG deleted; env indicates that the RSV gene for the envelope glycoprotein 
was inserted into the vector; CB indicates that the construction of the env 
and SV40 sequences was made at the ClaI and BamHI sites; 6)( signifies 
that a deletion has been made at the XhoI site; and n indicates the number 
of a specific mutant. Here we describe the characteristics of three deletion 
mutants: X1, X2, and X3. 
Growth of Virus 
After amplification, the vector shown in Fig. 1 B was digested with BamHI 
and recircularized to remove the plasmid sequences and to reduce its size 
to allow packaging into SV40 virions.  This recombinant virus and a late 
function helper (dM055) were used to cotransfect CV-1 cells by a modifica- 
tion of the procedure of Gething and Sambrook (1981). Approximately 300 
ng of SV40-env DNA and 75 ng of helper DNA was added to cells in 500 
ul of Tris-buffered saline containing 250 ug of DEAE-dextran (McCutchan 
and Pagano, 1968). After 60-90 min cells were washed with Tris-buffered 
saline and PBS, and incubated with medium containing 100 uM chloroquine 
(Luthman and Magnnsson,  1983) for 3-4 h. After 5-7 d when cytopathic 
effects were observed, cells were frozen and thawed three times, sonicated, 
and stored at  -70°C as virus stocks. 
Radiolabeling Gene Products 
Semiconfluent CV-1 cells were infected with a dilution of virus stock that 
produced extensive cympathic effects in 72-96 h. For biosynthetic labeling 
of env gene products, infected cells in 35-mm dishes were radiolabeled in 
1 ml of medium for 6 h with 100 ~tCi [3H]fucose (84 Ci/mmol, Amersham 
Corp., Arlington Heights, IL) or with 400-500 ~tCi [3H]palmitate (40-60 
Ci/mmol, New England Nuclear, Boston, MA) 60-72 h posfinfection. For 
pulse-chase experiments, cells were starved for leucine and serum for 1 h 
before labeling with  250  gCi (l  mCi/ml)  of [3H]leucine (60 Ci/rnmol, 
Amersham Corp.) for 15 rain. Duplicate dishes were chased with medium 
containing an excess of unlabeled amino acids for 3 h. To block glycosyla- 
tion,  cells were treated  with  1 iw,,/ml mnicamycin (Calbiochem-Behring 
Corp., La Jolla,  CA) 3 h before labeling with [3H]leucine and continu- 
ously during labeling. 
Immunoprecipitation and Gel Electrophoresis 
Cells were disrupted with 1 ml of lysis buffer A (1% Triton X-100, 1% so- 
dium deoxycholate, 150 mM NaCI, and 25 mM Tris-HC1 [pH 8.0]). Nuclei 
and cell debris were pelleted in a microcentrifuge. The supernatants were 
adjusted to a final concentration of 0.1% SDS. RSV-specific proteins were 
immunoprecipitated as previously described (Hardwick and Hunter,  1981; 
Hunter et al.,  1983) using antiglycoprotein antiserum and formalin-fixed 
Staphylococus aureus (Staph A). The antigen-antibody  complex was dis- 
sociated from the Staph A  by boiling in loading buffer (2%  SDS, 0.2 M 
2-mercaptoethanol,  10%  glycerol,  and 50 mM Tris-HCl  [pH 6.8]), and 
pelleted in a microcentrifuge. Samples were loaded onto 1.5-ram-thick Tris- 
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et al.,  1983). Radiolabeled polypeptides  were detected by fluorography 
using Enhance (New England Nuclear, Boston, MA). 
Fluorescent Staining of  Cells 
virus-specific glycoproteins were detected by immunolluorescent staining 
of fixed cells to detect intracellular material, and of live, unfixed ceils for 
detection of  glyeoproteins  on the cell surface, as described previously (Wills 
et al.,  1984). The Golgi apparatus was specifically stained in fluorescein- 
labeled fixed cells by treating them with rhodamine-conjugated  wheat germ 
agglutinin (E. Y. Laboratories, Inc., San Mateo, CA) that was diluted 1:10 
with PBS. Cells were treated for 30 min at room temperature (Wills et al., 
1984). 
Amino Acid Sequencing 
Microsequencing (Bhown et al.,  1980) of [3I-I]tryptophan  or [~H]leucine- 
labeled protein was accomplished by sequential Edman degradation in a 
Beckman 890M, automated sequencer (Beckman Instruments Inc., Fuller- 
ton, CA) as previously described (Hunter et al.,  1983). [3H]tryptophan (50 
Ci/mmol, Amersham Corp.) or [3H]leucine-labeled  polypeptides were iso- 
lated from 35-ram dishes of infected cells, pulse-labeled with 250 ~tCi of 
the appropriate radiolabeled amino acid, after a 1-h incubation in medium 
lacking either tryptophan  or leucine. Wdd-type or mutant env gene products 
were immunoprecipitated  as described above. To obtain the immunoprecipi- 
tared glycoproteins in a buffer suitable for injection into the protein se- 
quencer, the supernatants were subjected  to four cycles  of  centrifugation  and 
dilution in  1 mM  dithiothreitol and 0.01% SDS  using a  Centricon-30 
microconcentrator (Antic.on Corp., Danvers, MA), before sequencing. 
Results 
Construction and Expression of  Deletion Mutants 
Deletion mutations were introduced  into the coding region 
for the envelope glycoprotein of RSV by digestion of a plas- 
mid containing the env gene (Fig.  1 A) at a unique XhoI site 
located  13  bp  from the  5' end  of the  coding  sequence  for 
Figure 3.  Immunoprecipitation of intracellular  glycoproteins.  At 
60-72 h post infection, cells were incubated in medium without leu- 
cine or serum for 1 h  and then pulse-labeled with 250 IxCi [3H]- 
leucine per 35 mm dish for 15 min (P lanes).  Duplicate cultures 
were chased with unlabeled medium for 3 h (C lanes). Cell lysates 
were immtmoprecipitated with anti-glycoprotein rabbit antiserum 
and electrophoresed on an SDS-polyacrylamide gel. Viral precur- 
sor glycoprotein Pr95 and mature products gp85 and gp37 were ob- 
served as well as SV40 VP1 that was nonspecificaUy precipitated. 
gp85,  followed  by  digestion  with  the  double-strand  exo- 
nuclease, Bal. 31. Linear DNA was recircularized by ligation 
and then used to transform bacteria.  Potential mutants were 
identified by restriction enzyme analysis and DNA sequenc- 
ing. From the DNA sequence,  it was inferred that the poly- 
peptide product of mutant X1  had a  14 amino acid deletion 
that resulted in the loss of one potential glycosylation site; 
the signal peptidase cleavage site of this mutant protein re- 
mained unaltered (Fig. 2). The predicted products of mutants 
X2 and X3 both had deletions that began at the signal pepti- 
dase cleavage site and extended into gp85, nine amino acids 
and  six amino acids,  respectively. 
The mutant genes were cloned into the late region of SV40 
such that the env gene replaced the SV40 late genes and was 
under  control  of the late SV40  promoter (Fig.  1 B).  This 
recombinant virus was cotransfected  into CV-1  cells with a 
helper virus (d11055)  that provided late gene functions and 
allowed  virus  assembly.  Recombinant  virus  (and  helper) 
progeny were harvested and used to infect CV-1 cells at high 
multiplicities to study the biosynthesis and maturation of the 
mutated env gene products.  Mutant and wild-type construc- 
tions are detailed  in Materials  and  Methods. 
Cleavage of  the Precursor Pr95 to Mature 
Glycoproteins gp85 and gp37 
To determine if the mutant env genes yielded functional gene 
products,  infected  cells  were  pulse-chased  using  [3H]leu- 
cine,  then  env-related products  were  immunoprecipitated 
and electrophoresed  on SDS-polyacrylamide gels.  In a  15- 
rain pulse, the only env-related product synthesized was the 
Pr95 precursor (Fig.  3, P  lanes).  The cloned gene products 
appeared  to be very  similar  to those  produced  in  chicken 
cells  infected  with  RSV  (data  not  shown),  indicating  that 
the  precursors  were  translocated  normally  into  the  rough 
endoplasmic  reticulum  and  glycosylated.  The  uncleaved 
precursor that remains after the chase in both wild-type and 
mutant infected cells has an apparent molecular mass some 
3 kD smaller than that first seen in pulse-labeled cells (Fig. 
3,  C  lanes).  This reduction  may be due to the trimming of 
glucose residues  from the carbohydrate  side chains,  which 
has been shown to occur early in the transport pathways and 
before addition  of the terminal  sugars  (Hubbard and Ivatt, 
1981).  The pronounced size reduction of the glycosylated XI 
precursor is presumably because the deletion, in addition to 
removing 14 amino acids, resulted in the loss of one glycosy- 
lation  site. 
After a  3-h  chase,  the  cleavage products  gp85  and  gp37 
were present for mutants  X2 and X3 but not in the case of 
mutant X1  (Fig.  3,  C  lanes).  Therefore,  the deletion muta- 
tions in X2 and X3 have no apparent effect on processing of 
the mutant precursor to mature glycoproteins. The 14 amino 
acid deletion of X1, however, does appear to prevent process- 
ing  of the  altered  precursor,  although  it  does  not  cause  a 
rapid degradation of the polypeptide.  The nature of this de- 
fect will be discussed  in more detail below. 
Cleavage of the Signal Peptide 
One of the earliest processing events in the biosynthesis  of 
the env gene product is the cleavage of the signal-containing 
leader sequence from the amino end of the nascent polypep- 
tide (Hunter et al.,  1983).  To determine if the signal peptide 
was cleaved efficiently from the deletion  mutants,  infected 
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tures were labeled with [3H]leueine  in the absence (-) or presence 
(+) of 1 pg/ml tunicamycin (TM). Tunicamycin was added to the 
cells 3 h before labeling. Cell lysates were immunopreeipitated with 
anti-glycoprotein rabbit antiserum and electrophoresed on an SDS- 
polyacrylamide gel.  The unmarked band present  in all lanes is 
nonspecifically precipitated SV40 VP1. 
cell cultures were treated with tunicamycin, which blocks 
glycosylation of RSV  glycoproteins (Stohrer and  Hunter, 
1979). Treated and  untreated cells were then pulsed with 
[3H]leucine,  immunoprecipitated,  and  electrophoresed on 
polyacrylamide gels (Fig. 4). 
In the presence of tunicamycin, the wild-type env gene 
polypeptide precursor migrated as a protein of 54,000 D- 
the unglycosylated form of this molecule. The unglycosy- 
lated  mutant  precursors  were detectably smaller than the 
wild-type, consistent with the deletions having no effect on 
signal peptide cleavage. If the signal peptidase had failed to 
cleave  these  mutant  precursors,  the  additional  64  amino 
acids of the leader peptide would have resulted in an increase 
in size of the unglycosylated product to 60-63 kD,  which 
would have been easily discernible in the polyacrylamide gel 
system used (Hunter et al.,  1983). From these experiments, 
we conclude that all three mutants are translocated across the 
endoplasmic reticulum, are cleaved by the signal peptidase, 
and are glycosylated in a normal manner. The sizes of the 
unglycosylated forms of X1  and  X2  are  indistinguishable 
from each other (Fig. 4, TM [+] lanes), whereas the sizes 
of their glycosylated forms show a  small but reproducible 
difference (Fig. 4, TM [-] lanes and Fig. 3, p lanes). This 
provides further evidence that position  17 in gp85  is nor- 
mally glycosylated in the wild-type protein. 
Mutant X1 has a deletion beginning with the fourth amino 
acid of gp85 and thus retains an unaltered signal peptidase 
cleavage site.  Mutants X2 and X3 on the other hand, have 
deletions of nine and six amino acids, respectively, from the 
amino terminus of gp85, and thus alter the C-terminal side 
of the signal peptidase cleavage site. Amino acid sequencing 
was performed to determine directly whether the signal was 
removed and whether proteolysis occurred at the modified 
cleavage site in these two mutants. Infected ceils were pulse- 
labeled  with  [3H]tryptophan,  the  glycoproteins were  im- 
munoprecipitated, subjected to Edman degradation on an au- 
tomated sequencer, and the amount of radioactivity released 
at each cycle determined (Fig. 5). Radiolabeled tryptophan 
was recovered at positions 12 and 15 for the wild-type poly- 
peptide at positions 3 and 6 for mutant X2 product and at po- 
sitions 6 and 9 for mutant X3 protein (the counts in cycle 1 
for the latter appear to represent loss of sample from the 
spinning  cup).  Sequence  analyses  of  [3H]leucine-labeled 
proteins  yielded  results  consistent  with  those  described 
above (data not shown). These results confirm that the signal 
peptidase cleavage site is ala/asp for wild-type, ala/asn for 
X2, and ala/gln for X3. Thus, the signal peptidase cleaves 
at  the  same  position  relative to  the  signal  peptide,  even 
though the cleavage site sequence itself is altered. 
Localization of env Gene Products 
by Immunofluorescence 
CV-1 cells expressing the env gene were reacted with specific 
antiserum and  tagged  with  fluorescein-conjugated second 
antibody to determine if the mutant proteins could be found 
on the cell surface and distributed normally in intracellular 
comparlments (Figs. 6 and 7). Mutants X2 and X3 were ex- 
pressed on the cell surface as efficiently as the wild-type, 
judging from immunofluorescence (Fig. 6). Therefore, a de- 
letion of six or nine amino acids at the amino terminus of 
gp85 did not block transit to the cell surface. In contrast, CV- 
1 cells infected with the X1 mutant exhibited only trace sur- 
face fluorescence (Fig. 6). This observation correlates with 
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Figure 5. N-terminal amino acid sequence determination of wild- 
type and mutant Pr95 polypeptides. Infected SV-1 cells were labeled 
with  [3H]tryptophan for 20  min.  Proteins  immunoprecipitated 
from cell lysates were subjected to automated Edman degradation 
and the fractions were counted by liquid scintillation to determine 
which  cycles contained  radioactive tryptophan.  The peaks  cor- 
respond to the predicted tryptophan positions in the amino acid se- 
quence shown below. 
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type and mutant polypeptides. Live infected CV-I cells were stained 
to detect surface expression of the wild-type and mutant glycopro- 
teins.  Chicken  anti-glycoprotein  antibodies  were  tagged with 
fluorescein-conjugated rabbit  anti-chicken  IgG  for cell  surface 
labeling. Bright surface fluorescence can be observed with cells in- 
fected with wild-type and mutant-X2-and X3-containing vectors, 
whereas those containing the X1 mutant gene stained no brighter 
than uninfected cells. Bar, 10 lxm. 
the lack of  cleavage of  the X1 Pr95 to gp85 and gp37, suggest- 
ing that X1 is blocked at a point in maturation before cleav- 
age,  which  normally  occurs  before transport  to  the  cell 
surface. 
To determine the intracellular distribution of the mutant 
X1 polypeptide, fixed cells were stained with anti-glycopro- 
tein antibody and treated with rhodamine-conjugated wheat 
germ agglutinin which specifically stains the Golgi (Virtanen 
et al., 1980). The glycoproteins of wild-type and mutant X1, 
exhibited brilliant intracellular fluorescence that colocalized 
with that of the rhodamine-conjugated wheat germ aggluti- 
nin (Fig. 7). In contrast, mutant C3, an env gene mutant with 
a deletion in the C-terminus of gp37 whose transport is ar- 
rested  in  the  endoplasmic  reticulum  (Wills  et  al.,  1984) 
shows reduced fluorescein staining in the region of the Golgi 
rather than a bright area in wild-type and XI infected cells. 
Thus the mutant XI glycoproteins appear to be transported 
from the rough endoplasmic reticulum to a subcellular com- 
partment that colocalizes with the Golgi. The intracellular 
transport of mutant X1, therefore, appears to be blocked at 
a point beyond the rough endoplasmic reticulum, but before 
the plasma membrane. 
Modifications of Glycoproteins 
To further investigate the point in the transport pathway that 
X1 was blocked, we determined whether the glycoproteins 
had undergone modifications which are known to occur in 
the cis- and tmns-Golgi.  Palmitic acid  is added  near the 
membrane-spanning  region  of  many  viral  glycoproteins 
(Schmidt,  1982)  including  that  of RSV  (Gerhardt et  al., 
1984), and its addition is believed to occur in the cis compart- 
ment  of the  Golgi  apparatus  (Schmidt  and  Schlesinger, 
1980).  To determine whether all the mutant proteins were 
modified in this manner,  infected CV-1 cells were labeled 
with [3H]palmitic acid for 6 h and the env-specific  products 
were immunoprecipitated for gel analysis. [3H]Palmitic  acid 
predominantly labeled the gp37 polypeptide and, to a lesser 
extent, Pr95 of the wild-type. The gp85  did not label,  as 
might be expected since it does not traverse the lipid bilayer; 
gp37 being the bitopic membrane-spanning  component of 
the glycoprotein complex (Fig. 8). Mutants X2 and X3 be- 
hayed in an identical manner to wild-type in that the precur- 
sors  showed trace labeling while the gp37  polypeptide of 
each was heavily labeled. Because X1 is not cleaved to gp37 
and gp85, the bulk of palmitic acid modification (i.e., the 
sum of that added to both Pr95 and gp37 of wild-type, X2 
or X3) should occur on the uncleaved precursor if it enters 
the correct subcellular compartment. This does not appear 
to be the case because only trace levels of precursor labeling 
was observed. To rule out the trivial possibility that the low 
level of palmitate addition with X1 was due to poor expres- 
sion  or  recovery, parallel  dishes  were pulse-labeled  with 
[3H]leucine and the cell lysates were processed simultane- 
ously with the [3H]palmitate-labeled samples.  Similar lev- 
els of [3H]leucine-labeled precursor were recovered for all 
three mutants and the wild-type (Fig. 8). Therefore, we con- 
clude that the low level of palmitic acid labeling for Xl was 
due to the lack of palmitic acid modification and not due to 
low levels of expression or recovery. 
The labeling of wild-type Pr95 with palmitic acid sup- 
ports other evidence that palmitic acid addition occurs before 
cleavage of Pr95 to gp85 and gp37 (Wills et al.,  1984). The 
low level of incorporation of [3H]palmitate into the X1 poly- 
peptide may reflect some leakiness in the transport block or 
alternatively could indicate low levels of palmitate addition 
before the cis-Golgi compartment. 
Fucose is a terminal sugar of N-linked oligosaccharides 
and is believed to be added to the carbohydrate side chains 
Figure 7. Intracellular immunofluorescence of cells expressing wild-type and mutant polypeptides. Fixed infected CV-1 cells were stained 
to detect the  intracellular  localization of wild-type and mutant glycoproteins. Rabbit anti-glycoprotein  antibodies were tagged with 
fluorescein-conjugated goat anti-rabbit  antibodies which in wild-type and X1 infected cells could be localized on the nuclear membrane 
(NM),  endoplasmic reticulum (ER), and Golgi apparatus (G). The latter was localized by staining the same cells with rhodamine- 
conjugated wheat germ agglutinin. In mutant C3 infected cells neither the nuclear membrane nor the Golgi apparatus stained with the 
anti-glycopmtein antiserum. Bar, 10 I~m. 
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and fucosylation. Infected CV-1 cells were labeled with [3H]leu- 
cine, [3H]palmitic  acid, or [3H]fucose,  and the glycoproteins were 
immunoprccipitated and  electrophoresed on an SDS-polyacryl- 
amide gel, as described in Materials and Methods. The RSV env 
precursor and mature cleavage products are indicated by arrows. 
of glycoproteins in the trans compartment of the Golgi ap- 
paratus (Hubbard and Ivatt, 1981). The data in Fig. 8 indicate 
that [3I-l]fucose was incorporated in only trace amounts into 
mutant X1 polypeptides. Since the transport of a majority of 
the X1 polypeptides was blocked before proteolytic process- 
ing to gp3"/and gp85 and palmitic acid addition, it would also 
be expected to be blocked before fucose addition. The trace 
labeling of X1 polypeptides with fucose is primarily in a pro- 
tein with the mobility of gp85, thus a very small fraction of 
the mutant gene product does appear to escape the transport 
block. 
Discussion 
In  this  investigation we  have  studied the  role  of amino- 
terminal amino acid sequences  of gp85  in signal peptide 
cleavage and intracellular protein transport. Three mutants 
with deletions in the amino-terminal end of the RSV gp85 
were generated by Bal31 digestion from an XhoI site in the 
cloned env gene. These mutant genes were expressed in CV-1 
cells under the control of the SV40 late promoter. Mutant X1 
had a 14 amino acid deletion that began with the fourth amino 
acid of gp85 and extended to amino acid 17; this sequence 
includes one potential glycosylation site.  This deletion re- 
sulted in the synthesis of a slightly smaller precursor poly- 
peptide that lacked one carbohydrate side chain, but which 
otherwise appeared to be glycosylated normally. Based on 
size estimations in pulse-labeling experiments, in the pres- 
ence and absence of tunicamycin, the precursor polypeptide 
lacked the long, signal-containing leader peptide. Thus, al- 
though the mutation in X1 significantly alters the sequences 
near the signal peptidase site, the signal peptidase still recog- 
nized and removed the leader peptide.  Nevertheless,  im- 
munofluorescence experiments and posttranslational modi- 
fication probes indicate that the transport and maturation of 
the glycoprotein of X1 is halted shortly after exiting the en- 
doplasmic reticulum, perhaps within pre- or cis-Golgi vesi- 
cles.  A  determination of the exact location of the mutant 
molecules should be amenable to immuno-electron micros- 
copy. It cannot be determined from these experiments if the 
amino acid deletion, the lack of a carbohydrate side chain, 
or both, was responsible for the deficiency in transport of X1. 
The carbohydrate itself is probably not a signaling structure 
for transport to the Golgi because there are unglycosylated 
proteins that are transported through the cellular machinery 
(Strous and Lodish, 1980), and although several of  these pro- 
teins are normally glycosylated, they continue to be trans- 
ported in the presence of tunicamycin, an N-linked glycosy- 
lation inhibitor.  Nevertheless,  loss of a  carbohydrate side 
chain may alter the folding and tertiary structure of normally 
glycosylated proteins.  It will be  of interest to determine 
whether addition of a glycosylation site near the amino ter- 
minus of X1 restores its ability to be transported to the cell 
surface, because the addition of a  glycosylation site to a 
membrane anchored form of  the rat growth hormone confers 
on it the ability to be transported to the plasma membrane 
(Guan et al.,  1985). These experiments are in progress. 
We have previously reported on a different mutant of the 
RSV env gene that was also blocked in intraceUular trans- 
port.  This mutant, C3,  has an engineered deletion at the 
carboxy-terminus of gp37 that removed the cytoplasmic tail 
and transmembrane region (Wills et al., 1984). Its transport 
is clearly blocked at an earlier stage than the X1 mutant since 
it  was  localized in the endoplasmic reticulum and never 
reached the Golgi apparatus. Although these mutants contain 
alterations at opposite ends of the env gene product, they 
both appear to lack an element that normally signals their 
transport to and beyond the c/s-Golgi. The nature of  such sig- 
nals is not understood. While there may be a specific amino 
acid sequence (analogous to the amino-terminal signal se- 
quence) that is required for recognition and transport from 
the endoplasmic reticulum to the Golgi apparatus, and from 
the Golgi to the plasma membrane, it is possible that a cor- 
rectly aligned tertiary structure is the most critical factor in 
protein transport. 
Like the RSV glycoprotein, the influenza hemagglutinin 
(HA) glycoprotein is also synthesized as a precursor mole- 
cule with an amino-terminal signal peptide that is removed 
during translation. The precursor is further cleaved into HA1 
and HA2 either intracellularly or extracellularly. The three- 
dimensional structure of  HA determined by X-ray crystallog- 
raphy (Wilson et al., 1981) showed that the amino-terminus 
of HA1 is in close proximity to the HA2, because HA1 is 
folded  back  down  towards  the  membrane  where  HA2 
traverses the lipid bilayer. Therefore, the amino-terminus of 
HA1 may be critical in conferring an appropriate conforma- 
tion required for stability of a tertiary structure constrained 
within the lipid bilayer, and thus allow interaction with possi- 
ble  sorting  factors.  Indeed,  small changes  in the  amino- 
terminus of HA1 can disrupt assembly and transport of the 
HA trimer  (Wills,  J.  W.,  E.  Hunter,  and M.-J.  Gething, 
manuscript in preparation). The deleted amino acids unique 
to the X1 mutation may similarly play a critical role in the 
tertiary structure of the env-complex,  such that sorting sig- 
nals required for transport through the Golgi complex are 
lost. 
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begin at the amino-terminus of gp85 and extend nine amino 
acids (X2) and six amino acids (X3) into this structural pro- 
tein. Neither of these deletions include a glycosylation site, 
but they do overlap with the deletion in X1. Despite these 
changes, the X2 and X3 mutant glycoproteins were trans- 
ported to the cell surface and were indistinguishable from the 
wild-type. Mutants X2 and X3 thus indicate that the terminal 
nine amino acids of Pr95 are not required for normal intra- 
cellular transport. 
The deletion mutants X2 and X3 encode gp85 polypep- 
tides with novel amino-termini that alter the signal peptidase 
cleavage  site  from  ala/asp-val-his  to  ala/asn-leu-trp  and 
ala/gln-pro-gly, respectively. Thus both the charge and sec- 
ondary structure of the cleavage site would be predicted to 
be altered by the loss of asp and his (X2), and the relocation 
of  proline near the cutting side (X3). Nevertheless, the signal 
peptidase efficiently cleaves the leader peptide from the nas- 
cent polypeptide and its specificity of cleavage is unaffected 
by these alterations. Perlman and Halvorson (1983) and von 
Heijne (1983, 1984) have examined the sequence of almost 
100 different procaryotic and eucaryotic signal sequences to 
determine if there are specific sequences required for recog- 
nition by the signal peptidase.  Although there is no con- 
sensus sequence, there are definite patterns of amino acids 
that allow an accurate prediction of the cleavage site for 93 % 
of the eucaryotic signal peptides. In general, signal peptides 
have a positively charged amino acid preceding a hydropho- 
bic core, and although signal peptides vary in length, the dis- 
tance from the end of the hydrophobic core to the cleavage 
site is quite highly conserved; the most common length being 
five amino acids for eucaryotes and six for procaryotes (von 
Heijne, 1985). The last three amino acids of the signal pep- 
tide have a pattern of A-X-B where A is usually a small neu- 
tral residue (Ala, Val, Cys, Ser, or Thr) and B is usually ala, 
gly, or ser, while aromatic and charged residues are forbid- 
den at these positions. No amino acid distribution patterns 
were observed in the post-cleavage region.  Whereas it is 
clear that predicting the peptidase cleavage site from statisti- 
cal studies can be reasonably accurate, there are still other 
unknown contributing factors because there are a few exam- 
pies where the cleavage site is not at the expected position. 
Nevertheless, the experiments we report here support the 
generalized conclusion from statistical analysis, that the se- 
quence to the right of the peptidase cleavage site is not criti- 
cal for signal peptidase cleavage. 
None of the deletions generated in the RSV glycoprotein 
gene resulted in a loss of recognition and cleavage by the sig- 
nal  peptidase.  This  result  contrasts  with  previously  de- 
scribed procaryotic mutants. A 12 amino acid deletion start- 
ing at the fifth residue beyond the signal peptidase site of the 
/araB gene product blocked cleavage of the signal (Emr and 
Bassford, 1982; Emr et al., 1981) and a deletion of 130 amino 
acids beginning 70 amino acids downstream from the signal 
peptidase cleavage site of the same molecule, resulted in the 
abolition of signal cleavage although the shortened protein 
was localized correctly (Benson and Silhavy, 1983). In addi- 
tion, the substitution of a leucine, in place of the glutamic 
acid, at residue two of the mature MI3 coat protein also in- 
hibited signal peptidase cleavage, however,  in this latter in- 
stance  the  procoat  protein  was  transported  inefficiently 
across the inner membrane (Boeke et al., 1980; Russel and 
Model,  1981). Although more mutants will be required to 
properly define these systems, the procaryotic cleavage site 
appears to be more sensitive to manipulation than that of eu- 
caryotes. There is accumulating evidence that transported 
procaryotic proteins, unlike those of eukaryotes, may not be 
transferred across membranes in a  strictly cotranslational 
manner (Randall and Hardy,  1984). Thus altered regions 
within the structural protein portion of a  molecule would 
have the opportunity to interact and interfere with signal pep- 
tidase cleavage; such an interaction would not be possible in 
the cotranslational system described for eukaryotes. 
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Note Added in Proof.  Through using a mutagenic oligonucleotide we have 
modified the NH2-terminus of the mutant X1 gp85 from asp-val-his-arg- 
thr- to asp-val-asn-arg-thr-,  thereby reinserting the glycosylation site miss- 
ing from this mutant. Based on the size of the Pr95  produced from this 
modified gene, we conclude that glycosylation occurs at the new site, how- 
ever, the transport defect present in the original X1 mutant is retained. Thus 
the transport block reported for mutant X1 appears to be the result of the 
amino-acid deletion rather than loss of a  carbohydrate side chain. 
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